Reprint

The Role of Natural Products on Diabetes Mellitus Treatment

Edited by
January 2024
436 pages
  • ISBN978-3-7258-0010-0 (Hardback)
  • ISBN978-3-7258-0009-4 (PDF)

This book is a reprint of the Special Issue The Role of Natural Products on Diabetes Mellitus Treatment that was published in

Biology & Life Sciences
Chemistry & Materials Science
Medicine & Pharmacology
Summary

The utilization of medicinal plants in the treatment of diabetes mellitus (DM) holds significant promise due to their diverse bioactive compounds. These plants have been historically acknowledged for their potential in managing DM and its complications. They often contain secondary metabolites with inherent hypoglycemic properties, aiding in regulating blood glucose levels. Several plants and secondary metabolites have shown effectiveness in improving insulin sensitivity, enhancing glucose uptake, and mitigating the adverse effects associated with DM. For instance, bitter melon (Momordica charantia) contains charantin and polypeptide-p, both known for their hypoglycemic effects. Additionally, fenugreek (Trigonella foenum-graecum) exhibits hypoglycemic properties attributed to the presence of trigonelline and diosgenin.The complex array of bioactive compounds present in medicinal plants offers a multifaceted approach to managing DM. Flavonoids, alkaloids, polyphenols, and terpenoids found in these plants exert antioxidant, anti-inflammatory, and anti-glycation effects, mitigating oxidative stress and inflammation often associated with diabetic complications.This Special Issue highlights the role of natural products in the treatment of DM, including recent patents as well as the effects of characterized extracts and the cellular mechanisms of isolated secondary metabolites in preclinical and clinical studies.

Format
  • Hardback
License and Copyright
© 2022 by the authors; CC BY-NC-ND license
Keywords
narirutin; naringenin rutinoside; isonaringin; molecular docking; mechanism of action; enzyme; receptors; diabetes mellitus; neurotoxicity; curcumin nanoparticle; zinc oxide nanoparticle; metformin; inflammation; oxidative stress; apoptosis; acarbose; combination approach; Ecklonia radiata; fucoidan; type 2 diabetes management; Lavandula pedunculata (Mill.) Cav.; Punica granatum L.; Trigonella foenum-graecum L.; diabetes; glucose intestinal absorption; oral glucose tolerance test; pregnancy; type 1 diabetes mellitus; beta-cell; insulin; C-peptide; hypoglycemia; n-3 PUFA; placenta; fetus; oleuropein; Mediterranean diet; diabetes; metabolic syndrome; metformin; silymarin; combination therapy; liver steatosis; pre-diabetes; advanced glycation end products; diabetes; polydatin; salivary gland; diabetes mellitus; type 2; biological products; plants; antioxidants; therapeutics; natural products; phenols; ageing; diabetic cardiomyopathy; mitochondrial longevity; electron transport chain; BGP-15; nicotinic acid; NAD precursor; bioactive molecule; antioxidants; NA/STZ-induced diabetes mellitus; Balanitis aegyptiaca; fruit; seed; aqueous extracts; edible mushroom; insulin resistance; diabetes; polysaccharide; vitamin D; α-glucosidase; α-amylase; Artemisia absinthium; antioxidant activity; phenolic compounds; hyperglycemia; pancreatic α-amylase; intestinal α-glucosidase; rosinidin; streptozotocin; diabetes; lipid profile; proinflammatory cytokine; CXCL16; ADAM10; NF-κβ; apoptosis; pancreatic islets; resveratrol; T1D; sweeteners; D-Pinitol; carob fruit; insulin; insulin resistance; liver steatosis; pituitary hormones; type 2 diabetes; Chinese herbal medicine; YH1; gut microbiota; bile acids; diabetes; elderberry; yarrow; cornelian cherry; bilberry; wild strawberry; rosehip; raspberry; blackberry; stinging nettle; Trigonella foenum-graecum; fenugreek; prediabetes; type 2 diabetes; fasting blood glucose; post-prandial glucose; insulin; flavonoid; rutin; antioxidant; lipidosis; hyperglycemia; diabetes; diabetes mellitus; natural products; flavonoids; polyphenols; patent; marine natural products; Dysidea avara; sesquiterpene-type quinones; avarone; aldose reductase; protein tyrosine phosphatase 1B; dual target inhibitors; diabetes mellitus; Orthosiphon stamineus; GLUT4; anti-oxidant; diabetes mellitus; phytochemicals